左旋西孟旦
体外
单中心
医学
生命维持
重症监护医学
心力衰竭
心脏病学
内科学
作者
Bernhard Flörchinger,Zdeněk Provazník,Alois Philipp,Maik Foltan,Daniele Camboni,Leopold Rupprecht,Dirk Lunz,Christopher H. Schmid
标识
DOI:10.1055/s-0041-1725792
摘要
Objectives: Currently, treatment of heart failure patients with levosimendan (LEV) is critically discussed. This study evaluates the benefit of LEV in patients with postcardiotomy failure requiring ECLS.
科研通智能强力驱动
Strongly Powered by AbleSci AI